CLIENT PROFILES

ESTABLISHED ACHIEVEMENT SCALING UP EMERGING TECHNOLOGY COMPANIES
 

CAPITAL RAISE

 

Sold company vision to investors and Board in order to raise growth capital for US expansion. (Agendia, Biocartis, MDxHealth)

 

Developed investor information memoranda which generated a total of €50M in capital for various Life Sciences companies. (Agendia, MDxHealth)

 

Analyzed prospective financial information and made risk evaluations on prospectuses used on U.S., Canadian and U.K. security exchanges.


Prepared company budgets, forecasts and projections under various financing scenarios for life sciences companies used for investor marketing purposes. (Agendia, MDxHealth)

 

Prepared road-show documents. Answer complex investor queries. (Agendia)

STRATEGY, GROWTH AND INNOVATION
 

Served as a sounding board to CEOs of life sciences companies poised to expand into the US market - refining strategic and financial plans. (MDxHealth, Agendia)


Presented and sold alternative strategy scenarios to various life science company Boards achieving buy-in. (MDxHealth)

 

Coached various technology startups (Blockchain, 3-D Printing, Smart meters, Face and voice recognition, Solar and wind, Predictive analytics, Big data, IOT) on innovative business models, customer-centric focus, expansion into new markets and strategic alliances. (Rockstart, Startupbootcamp)

 

Objective voice to CEO of a molecular diagnostics company in the formulation of a new company culture and management team. (MDxHealth)

STRATEGIC ACQUISITIONS

 

Negotiated a $1B joint venture for a large international electronics manufacturer (Philips) in Korea. Client paid $250M less as a result.

 

Assessed business and financial risks when buying, merging, or selling a company / business for various Fortune 500 companies (consumer goods, software, energy, transport).
Deal size: from €50M to €1 B.  (Philips, Inbev)
Deal types: M&A, Management Buyouts, Vendor Due Diligence.

BUSINESS IMPROVEMENT

 

Through strategic scenario modeling, implemented cross-border emergency short-term cost cutting for various life sciences companies. (Agendia, MDxHealth)

Recruited by the CFO at a global bank (ABN AMRO) to strategically reduce the cost base of the back office resulting in an annual expense reduction of €100M.

Partnered with leads in finance, marketing, and human resources at a global bank to produce an execution plan resulting in more optimal use of resources and increased productivity. (ABN AMRO)

© 2015 Innoviance Consulting BV. All rights reserved.